Acorn Capital Advisors’s BIOATLA INC BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Sell
108,126
-1
-0% -$4 0.12% 19
2026
Q1
$865K Buy
108,127
+11,425
+12% +$134K 0.25% 21
2025
Q4
$2.76M Hold
96,702
0.93% 17
2025
Q3
$3.34M Hold
96,702
1.69% 14
2025
Q2
$1.91M Buy
96,702
+16,061
+20% +$326K 1.25% 16
2025
Q1
$1.41M Hold
80,641
0.94% 19
2024
Q4
$2.38M Buy
+80,641
New +$6.77M 1.28% 19

Other funds holding BCAB

Acorn Capital Advisors's BCAB Position: Q2 2026 in Review

Acorn Capital Advisors reduced its BIOATLA INC (BCAB) stake by 0% in Q2 2026, selling an estimated $4 and leaving 108,126 shares worth $448K. The position accounts for 0.12% of the portfolio, ranked #19.

Acorn Capital Advisors first reported a position in BCAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.34M in Q3 2025. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Acorn Capital Advisors held 108,126 shares of BIOATLA INC worth $448K as of Q2 2026.
  • Acorn Capital Advisors sold 1 BIOATLA INC share in Q2 2026, an estimated $4.
  • BIOATLA INC made up 0.12% of Acorn Capital Advisors's portfolio in Q2 2026, its #19 holding.
  • Acorn Capital Advisors first reported a position in BIOATLA INC in Q4 2024 and has held it in 7 quarters since.
  • Acorn Capital Advisors's BIOATLA INC position peaked at $3.34M in Q3 2025.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Acorn Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.